In our pharmaceutical market research reports we focus largely on the emerging and the niche trends in the global pharmaceutical space. Due to the changing lifestyle and food habits, growth in the number of patients suffering from chronic disease is recorded. This is a good business opportunity in the space as the numbers of patients with such diseases are expected to explode in the coming years. In fact, if we look closely, the pharmaceutical market has already started gaining momentum. The pharmaceutical segment is likely to reach $1.3 trillion by 2018 as per consensus estimates. But in our pharmaceutical market research report we laser focus on the global depression therapy and treatment market along with extensive study on global in-vitro fertilization & male and female fertility treatment market.
In our pharmaceutical industry analysis we also explain why global depression therapy and treatment is a solid growth opportunity? According to research carried out in the past it has been revealed that females are more prone to clinical depression. Moving further, anti-depressant drug market used to be a leader in this space but nowadays people are relying much on devices and therapies which is a positive sign for pharmaceutical market share and growth. Patients are now rapidly inclining towards devices and therapies such as Fischer Wallace Stimulator, Virtual reality and Deep Brain Stimulator, Tran cranial Magnetic Stimulator, Vagus Nerve Simulator and light therapy. On the back of such an improvement, the global pharmaceutical market is likely to grow at a compounded annual growth rate of 4%-7% for the next five years.
However, things don’t look smooth as the pharmaceutical industry trends can face some headwinds on the back of various other factors such as expiration of patents which might affect the key players in the market. The higher therapy and device prices might also be a challenge for the pharmaceutical market.